At the MichBio Expo in Lansing, the outlook for the state's life sciences industry was good, despite Pfizer's decision to shut down facilities in Ann Arbor and Kalamazoo.
Excerpt: All discussions centered on forward-looking topics such as adaptive clinical trial design, foreign regulatory issues, the rapidly growing medical devices industry and biomaterials.
Read entire article here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.